BackTelomir Pharmaceuticals Overview

Telomir Pharmaceuticals Accounts Payable

Track Telomir Pharmaceuticals's accounts payable ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer trimmed avg / median

Loading

Telomir Pharmaceuticals Accounts Payable History

Loading

Telomir Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

Telomir Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Telomir Pharmaceuticals (TELO) FAQ

As of the most recent data (June 2026), TELO shows a accounts payable of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TELO's accounts payable is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Telomir Pharmaceuticals is outperforming or lagging.

Tracking TELO's accounts payable over time shows whether Telomir Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Telomir Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.